Role of stimulant replacement therapy in treating stimulant use disorders: Within the context of the COVID-19 pandemic

Can Fam Physician. 2022 Feb;68(2):109-111. doi: 10.46747/cfp.6802109.
No abstract available

MeSH terms

  • COVID-19*
  • Central Nervous System Stimulants* / therapeutic use
  • Humans
  • Pandemics
  • SARS-CoV-2
  • Substance-Related Disorders*

Substances

  • Central Nervous System Stimulants